Paclitaxel and Cisplatin with Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Stage IIIB Non-small Cell Lung Cancer
![]() |
Kang, Ki-Mun
(Departments of Radiation Oncology, Gyeongsang National University School of Medicine)
Lee, Gyeong-Won (Departments of Internal Medicine, Gyeongsang National University School of Medicine) Kang, Jung-Hoon (Departments of Internal Medicine, Gyeongsang National University School of Medicine) Kim, Hoon-Gu (Departments of Internal Medicine, Gyeongsang National University School of Medicine) Lee, Won-Seob (Departments of Internal Medicine, Gyeongsang National University School of Medicine) Chai, Gyu-Young (Departments of Radiation Oncology, Gyeongsang National University School of Medicine) |
1 | Jordan MA, Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 1998;10:123-130 DOI ScienceOn |
2 | Mason KA, Hunter NR, Milas M, Abbruzzese JL, Milas L. Docetaxel enhances tumor radioresponse in vivo. Clin Cancer Res 1997;3:2431-2438 |
3 | Dillman RO, Herndon J, Seagren SL, Eaton WL Jr, Green MR. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 1996;88:1210-1215 DOI ScienceOn |
4 | Park HC, Kim SS, Bae HS, et al. Induction chemotherapy followed by concurrent chemoradiotherapy in patients with unresectable stage III non-small cell lung cancer. J Lung Cancer 2005;4:27-33 |
5 | Sause WT, Scott C, Taylor S, et al. Phase II trial of combination chemotherapy and irradiation in nonsmall cell lung cancer, Radiation Therapy Oncology Group 88-04. Am J Clin Oncol 1992;15:163-167 |
6 | Bunn PA Jr, Kelly K. New treatment agents for advanced small and non-small cell lung cancer. Semin Oncol 1995;22: 53-63 |
7 | Cho KW. Multidisciplinary management of the locally advanced unresectable non-small cell lung cancer. J Korean Soc Ther Radiol Oncol 2004;22:1-10 |
8 | Leong SS, Fong KW, Ong YK, et al. Chemo-radiotherapy for stage III unresectable non-small cell lung cancer long-term results of a prospective study. Respir Med 2004;98:1080-1086 DOI ScienceOn |
9 | Belani CP, Choy H, Bonomi P, et al. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol. J Clin Oncol 2005; 23:5883-5891 DOI ScienceOn |
10 | Ramanathan RK, Belani CP. Chemotherapy for advanced non-small cell lung cancer: past, present, and future. Semin Oncol 1997;24:440-454 |
11 | Scagliotti GV, Szczesna A, Ramlau R, et al. Docetaxel- based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer. Br J Cancer 2006; 94:1375-1382 DOI ScienceOn |
12 | Douple EB, Richmond RC, O'Hara JA, Coughlin CT. Carboplatin as a potentiator of radiation therapy. Cancer Treat Rev 1985;12:111-124 DOI ScienceOn |
13 | Scagliotti GV, Turrisi AT 3rd. Docetaxel-based combined- modality chemoradiotherapy for locally advanced non-small cell lung cancer. Oncologist 2003;8:361-374 DOI ScienceOn |
14 | Komaki R, Scott C, Ettinger D, et al. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04. Int J Radiat Oncol Biol Phys 1997;38:149-155 |
15 | Kim SS, Choi EK, Kim JH, et al. Preliminary results of the prospective randomized phase III trial on the induction chemotherapy in the concurrent chemoradiotherapy for the locally advanced non-small cell lung cancer. J Lung Cancer 2004;3: 86-93 |
16 | Huber RM, Flentje M, Schmidt M, et al. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non–small-cell lung cancer: Study CTRT99/97 by the Bronchial Carcinoma Therapy Group. J Clin Oncol 2006;24:4397-4404 DOI ScienceOn |
17 | Perez CA, Pajak TF, Rubin P, et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 1987;59:1874-1881 DOI ScienceOn |
18 | Davies A, Gandara DR, Lara P, Goldberg Z, Roberts P, Lau D. Current and future therapeutic approaches in locally advanced (stage III) non-small cell lung cancer. Semin Oncol 2002;29:10-16 |
19 | Ginsberg RJ, Vokes EE, Raben A. Principle of cancer management: Chemotherapy. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principle and practice of oncology, 6th edit, Philadelphia: Lippincott-Raven, 2001:437-445 |
20 | Feigal EG, Christian M, Cheson B, Grever M, Friedman MA. New chemotherapeutic agents in non-small-cell lung cancer. Semin Oncol 1993;20:185-201 |
21 | Choy H, Rodriguez FF, Koester S, Hilsenbeck S, Von Hoff DD. Investigation of taxol as a potential radiation sensitizer. Cancer 1993;71:3774-3778 DOI ScienceOn |
22 | Trodella L, De Marinis F, D'Angelillo RM, et al. Induction cisplatin-gemcitabine-paclitaxel plus concurrent radiotherapy and gemcitabine in the multimodality treatment of unresectable stage IIIB non-small cell lung cancer. Lung Cancer 2006;54: 331-338 DOI ScienceOn |
23 | Annual report of the cause of deaths in Korea. Ministry of Health and Welfare 2004 |
![]() |